Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Hypercapnic Chronic Obstructive Pulmonary Disease and Overlap Syndrome
Justin A Fiala1, John M Coleman1
1Division of Pulmonary and Critical Care, Department of Medicine, Northwestern University Feinberg School of Medicine, Canning Thoracic Institute, 211 East Ontario Street, Suite 600, Chicago, IL 60611, USA.
Noninvasive ventilation (NIV) use in chronic obstructive pulmonary disease (COPD) with hypercapnic respiratory failure presents challenges, particularly transitioning from hospital to home care. This review clarifies evidence and guidelines for NIV application in these complex patients.
Area of Science:
- Pulmonary Medicine
- Critical Care Medicine
Background:
- The application of noninvasive ventilation (NIV) for hypercapnic chronic obstructive pulmonary disease (COPD) respiratory failure and overlap syndromes remains a complex clinical area.
- Navigating the specific timing and indications for NIV use in the United States presents significant practical challenges for healthcare providers.
- While NIV's efficacy in acute hospitalization for COPD exacerbations is established, its transition to home care is a subject of ongoing debate.
Purpose of the Study:
- To elucidate the current evidence, interventions, and optimal timing for initiating and continuing NIV in patients with hypercapnic COPD.
- To provide clarity on insurance guidelines related to NIV therapy for chronic hypercapnic respiratory failure.
- To assist healthcare providers in making informed decisions regarding NIV management for COPD patients transitioning from inpatient to home settings.
Main Methods:
- Comprehensive review of existing literature on NIV for hypercapnic COPD.
- Analysis of clinical practice guidelines and expert consensus statements.
- Examination of insurance policies and reimbursement criteria for home NIV.
Main Results:
- Evidence supports NIV in acute settings, but transitioning to home NIV for chronic hypercapnic COPD requires careful patient selection and management.
- Specific criteria and interventions can facilitate successful home NIV implementation.
- Understanding insurance coverage is crucial for patient access and adherence to home NIV.
Conclusions:
- Bridging NIV from inpatient to home settings for hypercapnic COPD patients is feasible but requires a structured approach.
- Further research and standardized protocols are needed to optimize long-term NIV outcomes.
- This review provides a framework to aid healthcare providers in managing NIV for COPD patients in the community.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Acute Respiratory Failure-III
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

